Zain Khalpey: Secondary Stroke Prevention as The Most Important Opportunity to Reduce Disability
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on LinkedIn about a recent article by Karen L. Furie and Peter J. Kelly, published in NEJM:
”Secondary prevention remains one of the most important opportunities to reduce long term disability after ischemic stroke.
A recent review in the New England Journal of Medicine emphasizes that lowering recurrence risk depends on identifying the underlying stroke mechanism and aggressively targeting modifiable risk factors early.
Effective care extends beyond the acute event.
Early diagnostic evaluation, timely initiation of preventive therapies, and ongoing monitoring of blood pressure, rhythm disorders, lifestyle factors, and medication adherence are central to reducing recurrent stroke risk.
The focus is increasingly shifting toward structured longitudinal care, combining mechanism specific treatment with continuous risk assessment to improve outcomes after stroke.”
Title: Secondary Prevention after Ischemic Stroke
Authors: Karen L. Furie, Peter J. Kelly
Read the Full Article on NEJM
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention